117 studies found for:    Acromegaly
Show Display Options
Rank Status Study
21 Completed
Has Results
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Condition: Acromegaly
Interventions: Drug: Somatuline Autogel (lanreotide acetate);   Behavioral: Home administration
22 Terminated Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide
23 Completed Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
24 Active, not recruiting Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
Condition: Acromegaly
Intervention:
25 Completed Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
Conditions: Acromegaly;   Diabetes;   Insulin Resistance;   Impaired Glucose Tolerance
Intervention:
26 Active, not recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide;   Drug: Octreotide
27 Completed Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide LAR
28 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease,;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
29 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
30 Active, not recruiting Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
Conditions: Acromegaly;   Surgery
Intervention:
31 Unknown  Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
32 Active, not recruiting Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230);   Drug: octreotide LAR 30mg;   Drug: lanreotide ATG 120mg
33 Active, not recruiting Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Condition: Acromegaly, Pituitary Gigantism
Intervention: Drug: SOM230LAR
34 Completed Physiopathology of Sodium Retention in Acromegaly
Condition: Acromegaly
Intervention: Drug: furosemide
35 Completed Prediction of Tumor Shrinkage in Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
36 Completed Somatuline Autogel: Acromegaly Self/Partner Injection Study
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
37 Recruiting Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
Condition: Acromegaly
Intervention: Other: Non-interventional cross-sectional survey
38 Recruiting Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
Condition: Acromegaly
Intervention:
39 Completed Description of the Association of Signs and Symptoms Present at Acromegaly Diagnosis
Condition: Acromegaly
Intervention:
40 Active, not recruiting Brain-gut Interaction in Irradiated Patients With Acromegaly
Condition: Acromegaly
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years